Fintel reports that on February 6, 2025, Leerink Partners downgraded their outlook for Hologic (NasdaqGS:HOLX) from Outperform to Market Perform. Analyst Price Forecast Suggests 20.21% Upside As ...

Leerink downgraded Hologic (HOLX) to Market Perform from Outperform with a price target of $75, down from $80, following the fiscal Q1 report. The company continues to experience a number of ...

Leerink Partnrs also issued estimates for Owens & Minor’s Q2 2025 earnings at $0.39 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.48 EPS, FY2025 earnings at $1.58 EPS, FY2026 ...

Hungry Howie’s is kicking off National Pizza Day and the Big Game with a new addition to its Secret Menu, the Hangry Howie pizza. Perfect for game day gatherings and pizza parties, the Hangry Howie is ...

Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (LSE:0R2M) from Market Perform to Outperform. There are 2,471 funds or institutions ...

During his many stops on Radio Row, Garrett sat down with Eagles beat reporter Eliot Shorr-Parks, who tossed out the idea of potentially coming to Philadelphia and noted Howie Roseman's ...

In a league that is constantly looking for parity, how do you remain at the top of the NFL food chain? One word – relentlessness. You hunt relentlessly with a hyper aggressive game plan.

Sometimes a promotion isn’t really a promotion. At least not in the case of Howie Roseman, who oversaw the Philadelphia Eagles’ free agency and draft strategy from 2010 to 2014, only to have ...

Caleb, who stirred the pot within the Dingle clan since his arrival during a past Christmas with a mysterious agenda, was revealed to be aiming for vengeance against Kim Tate due to his father ...

Bill Burr isn't happy with Howie Mandel. During a Monday appearance on "The Rich Eisen Show," the comedian, 56, slammed Mandel for surprising him with Billy Corgan during a recent podcast interview.

MONTREAL, Feb. 3, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its ...